James Christensen Buys 32,000 Shares of BOLD
James Christensen added 32,000 shares of BOLD to his holdings on June 15, 2026.
Key Points
- On June 15, 2026, James Christensen bought 32,000 shares of BOLD, marking a substantial personal investment.
- BOLD shares are currently trading at $1.41, with institutional investors also adjusting their positions.
- FMR LLC increased its stake in BOLD by 11,433 shares, while Citadel Advisors reduced its holdings by 11,773 shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
James Christensen, an insider at BOLD, purchased 32,000 shares of the company on June 15, 2026. This transaction was not part of a pre-planned trading program. Shares of BOLD are currently trading at $1.41.
Other Institutional Activity in BOLD
FMR LLC grew its holdings in BOLD by 11,433 shares, ending with 2,695,455 shares valued at approximately $2.97 million. On the other hand, Citadel Advisors LLC reduced its position by 11,773 shares, holding 1,342,131 shares worth about $1.48 million. Sectoral Asset Management Inc maintained its position with 678,574 shares valued at $746,431. Stonepine Capital Management, LLC cut its stake by 112,389 shares, resulting in 597,682 shares valued at $657,450. Notably, Vanguard Capital Management LLC initiated a new position with 597,192 shares, valued at around $656,911.
Insider Buying and Selling at Boundless Bio, Inc.
Several insiders made significant purchases on June 15, 2026. Alongside James Christensen, Jennifer Lew, Nancy Whiting, and Jonathan Lim each bought 32,000 shares. David Hinkle, Senior VP, Finance, Controller, and Treasurer, had previously acquired 140,000 shares on January 23, 2026. Zachary Hornby, President & CEO, also bought 600,000 shares on the same January date.
Analysts Set New Price Targets
On August 11, 2025, HC Wainwright & Co. maintained a 'buy' rating on BOLD with a price target of $4. Leerink Partners downgraded the stock to 'hold' with a target of $3 on May 28, 2025. Previously, on June 2, 2025, HC Wainwright & Co. had initiated coverage with a 'buy' rating and a $5 target.
Bottom Line
James Christensen's recent purchase of BOLD shares highlights his confidence in the company's prospects. Institutional investors are also adjusting their positions, which could reflect varying outlooks on BOLD's future performance. While analyst opinions are mixed, with some maintaining 'buy' ratings and others downgrading to 'hold', these moves are closely watched by investors looking to gauge the company's potential.
Get Boundless Bio, Inc. alerts
New 13F filings, insider trades, and analyst moves on $BOLD, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.